44
In band
Moving averages
SMA 200$97.63-0.96%
Company profile
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$24.30B
P/E ratioNone
EPS$-7.83
Beta1.293
Dividend yield0.00%
52-week high$124.00
52-week low$79.52
Similar stocks in Biotechnology
VRTX
Vertex Pharmaceuticals Inc
RSI 46
CRSP
CRISPR Therapeutics AG
RSI 44
IOVA
Iovance Biotherapeutics Inc
RSI 69
MRNA
Moderna Inc
RSI 62
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 57
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
RSI alerts for BNTX
Get an email the moment BioNTech SE crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 1:56 AM EDT